Literature DB >> 4886589

Cardiovascular effects of AH.3365 (salbutamol).

G R Kelman, K N Palmer, M R Cross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4886589     DOI： 10.1038/2211251a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Evaluation of the effects of isoprenaline and salbutamol aerosols on airways obstruction and pulse rates of children with asthma.

Authors:  G Hambleton; E A Shinebourne
Journal:  Arch Dis Child       Date:  1970-12       Impact factor: 3.791

2.  Comparison of effect of salbutamol and isoprenaline on spirometry and blood-gas tensions in bronchial asthma.

Authors:  K N Palmer; J S Legge; W F Hamilton; M L Diament
Journal:  Br Med J       Date:  1970-04-04

Review 3.  Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.

Authors:  Shelley R Salpeter; Nicholas S Buckley
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

4.  Comparison of two oral selective beta2-adrenergic stimulant drugs in bronchial asthma.

Authors:  J S Legge; J Gaddie; K N Palmer
Journal:  Br Med J       Date:  1971-03-20

5.  Effects of salbutamol and isoprenaline-phenylephrine in reversible airways obstruction.

Authors:  R J Alliott; B D Lang; D R Rawson; W J Leckie
Journal:  Br Med J       Date:  1972-02-26

6.  Cardiorespiratory effects of intravenous isoprenaline and salbutamol in dogs.

Authors:  L Loh; R F Seed; M K Sykes
Journal:  Br J Pharmacol       Date:  1971-03       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.